4.7

4.70 (-2.26%)

As of Mar 06, 2024

SUTRO BIOPHARMA, INC. [STRO]

Source: 

Company Overview

Sutro Biopharma, Inc. is a clinical-stage oncology company developing site-specific and novel-format antibody drug conjugates, or ADCs, enabled by our proprietary integrated cell-free protein synthesis platform, XpressCF®, and our site-specific conjugation platform, XpressCF ®. We aim to design and develop therapeutics using the most relevant and potent modalities, including ADCs, bispecific ADCs, immunostimulatory ADCs, or iADCs, dual conjugate ADCs, or ADC2s, and cytokine derivatives.

CountryUS
Headquarterssouth san franciscocalifornia
Phone Number(650) 392-8412
Industrybiological products (no diagnostic substances)
CEOWilliam J. Newell
Websitewww.sutrobio.com